A report in The New Scientist presents claims that the first baby was born in Mexico by a New York based doctor using mitochondrial replacement therapy...
NYSCF partnered with the American Museum of Natural History in New York on their learning exhibition “The Science of Stem Cells in the Sackler Educational Laboratory.”...
NYSCF – Robertson Stem Cell Investigator Alumnus and 2014 NYSCF – Robertson Stem Cell Prize recipient Dr. Marius Wernig, Stanford University, published his latest research dissecting...
Stem cell lines resulting from a pathbreaking collaboration beginning in 2014 between The NYSCF Research Institute and the Charcot-Marie-Tooth Association (CMTA) are now available for use...
In the human body, adult tissues replace lost cells via pools of stem cells. However, the mechanisms of this process are not fully understood. NYSCF –...
NYSCF – Robertson Stem Cell Investigator Dr. Ravindra Majeti, Stanford University School of Medicine, improved on human blood disease modeling using mouse models. The research, published...
Human stem cells require a certain cocktail of molecules to maintain their pluripotent state. Bone morphogenic proteins, or BMPs, promote differentiation in human cells, therefore molecules...
NYSCF has been at the forefront of bringing mitochondrial replacement therapy to the clinic and in 2011, published a seminal paper in Nature that showed mitochondrial replacement could...
The 3D structure of a cell’s genetic code, or genome, helps guide genetic expression. Though it is known that this structure is rearranged in somatic cells...
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
NYSCF does not treat patients with stem cell therapies. Please visit www.clinicaltrials.gov for a complete listing of clinical trials being conducted worldwide, or consult your physician. Stem cell research...
The NYSCF Global Stem Cell Array is a revolutionary robotic technology, developed by NYSCF, that automates and standardizes the production of stem cell lines and adult...
NYSCF wants to transform stem cell treatments from dreams to reality. In order to move stem cell-based cures from the theoretical and into clinics, scientists must...
The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and...
The New York Stem Cell Foundation (NYSCF) applauds the National Academies of Sciences, Engineering, and Medicine’s Institute of Medicine (IOM) report released on February 3rd, 2016...
NYSCF – Druckenmiller Fellow Larry Luchsinger, PhD, studies the energy producing centers of the cell, mitochondria, to better understand the cells that produce blood cells, hematopoietic...
NYSCF – Robertson Investigator Dr. Alexander Meissner, Broad Institute of MIT and Harvard, along with NYSCF – Robertson Investigator Dr. Gabsang Lee, John Hopkins University, explored...
NYSCF – Robertson Neuroscience Investigator Dr. Paola Arlotta, Harvard Stem Cell Institute and the Broad Institute of Harvard and MIT, showed that neuronal networks of communication...
At The 2015 NYSCF Conference: Tenth Annual Translational Stem Cell Research Conference, NYSCF announced Franziska Michor. PhD, as the 2015 recipient of the Robertson Stem Cell...
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
The National Institute of Health (NIH) invited Susan Solomon to chair and moderate a panel at September’s NIH Workshop on Reproducibility in Cell Culture Studies. The...
NYSCF announces a new partnership with Q-State Biosciences (Q-State) to generate high quality stem cells from patient blood cells. The collaboration will mark the first time...
NYSCF Vice President of Stem Cell Research, Dr. Scott Noggle leads The Stem Cell Podcast through a behind-the-scenes view of NYSCF’s one-of-a-kind robotic technology that creates...
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, published his latest work studying the development and interaction of binding factors in mouse stem...
NYSCF designed and has built a revolutionary, high-throughput robotic platform that automates and standardizes the process of transforming patient samples into stem cells. This one-of-a-kind system...
